Docoh
Loading...

Tue. 4 May 2021, 6:43am ETBenzinga
In: Earnings, News
Jounce Therapeutics (NASDAQ:JNCE) reported quarterly losses of $(0.58) per share which missed the analyst consensus estimate of $(0.41) by 41.46 percent. This is a 25.64 percent increase over losses of $(0.78) per share from the same period last year.